Osaic Holdings’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
Other funds holding MTNB
HIW
SIG
Osaic Holdings's MTNB Position: Q2 2026 in Review
Osaic Holdings increased its Matinas BioPharma (MTNB) stake by 4% in Q2 2026, buying an estimated $1 and bringing the position to 52 shares worth $31. The position accounts for ﹤0.01% of the portfolio, ranked #7907.
Osaic Holdings first reported a position in MTNB in Q1 2020 and has held it in 26 quarters since. The position peaked at $34K in Q3 2021. 25 funds tracked by Wall St. Rank hold MTNB as of Q2 2026.
- Osaic Holdings held 52 shares of Matinas BioPharma worth $31 as of Q2 2026.
- Osaic Holdings bought 2 Matinas BioPharma shares in Q2 2026, an estimated $1.
- Matinas BioPharma made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7907 holding.
- Osaic Holdings first reported a position in Matinas BioPharma in Q1 2020 and has held it in 26 quarters since.
- Osaic Holdings's Matinas BioPharma position peaked at $34K in Q3 2021.
- 25 funds tracked by Wall St. Rank held Matinas BioPharma as of Q2 2026.
Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.